Theravance Biopharma, Inc. Income Taxes Paid
Theravance Biopharma, Inc. (TBPH) reported Income Taxes Paid of $5.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-11
- Theravance Biopharma, Inc. income taxes paid, net for the quarter ending 2026-06-30 was $5.92M, a 33.46% decline year-over-year.
- Theravance Biopharma, Inc. income taxes paid, net for the quarter ending 2026-03-31 was -$351.00K, a 8875.00% decline year-over-year.
- Theravance Biopharma, Inc. income taxes paid, net for the quarter ending 2025-12-31 was $6.21M, a 6302.06% increase year-over-year.
- Theravance Biopharma, Inc. income taxes paid, net for the quarter ending 2025-09-30 was $12.77M.
- Theravance Biopharma, Inc. income taxes paid, net for fiscal 2025 was $27.88M, a 25481.65% increase from fiscal 2024.
- Theravance Biopharma, Inc. income taxes paid, net for fiscal 2024 was $109.00K, a 354.17% increase from fiscal 2023.
- Theravance Biopharma, Inc. income taxes paid, net for fiscal 2023 was $24.00K, a 99.98% decline from fiscal 2022.
- Theravance Biopharma, Inc. income taxes paid, net for fiscal 2022 was $117.97M.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $5.57M 10-Q · filed 2026-08-11 | $11.78M derived: sum of 3 quarters · filed 2026-08-11 | $24.55M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$351.00K 10-Q · filed 2026-05-07 | $5.86M derived: sum of 2 quarters · filed 2026-05-07 | $18.63M derived: sum of 3 quarters · filed 2026-05-07 | $27.53M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $6.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $18.98M derived: sum of 2 quarters · filed 2026-03-23 | $27.88M derived: sum of 3 quarters · filed 2026-08-11 | $27.88M 10-K · filed 2026-03-23 |
| 2025-09-30 | $12.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $21.67M derived: sum of 2 quarters · filed 2026-08-11 | $21.67M 10-Q · filed 2025-11-12 | $21.77M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $8.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $8.90M 10-Q · filed 2026-08-11 | $9.00M derived: sum of 3 quarters · filed 2026-08-11 | $9.00M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $4.00K 10-Q · filed 2026-05-07 | $101.00K derived: sum of 2 quarters · filed 2026-05-07 | $101.00K derived: sum of 3 quarters · filed 2026-05-07 | $122.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $97.00K derived: sum of 2 quarters · filed 2026-03-23 | $118.00K derived: sum of 3 quarters · filed 2026-03-23 | $109.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $21.00K derived: sum of 2 quarters · filed 2025-11-12 | $12.00K 10-Q · filed 2025-11-12 | $22.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $12.00K 10-Q · filed 2025-08-13 | $22.00K derived: sum of 3 quarters · filed 2025-08-13 | $22.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$9.00K 10-Q · filed 2025-05-12 | $1.00K derived: sum of 2 quarters · filed 2025-05-12 | $1.00K derived: sum of 3 quarters · filed 2025-05-12 | $8.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $10.00K derived: sum of 2 quarters · filed 2025-03-07 | $17.00K derived: sum of 3 quarters · filed 2025-03-07 | $24.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $7.00K derived: sum of 2 quarters · filed 2024-11-14 | $14.00K 10-Q · filed 2024-11-14 | $117.95M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $14.00K 10-Q · filed 2024-08-08 | $117.95M derived: sum of 3 quarters · filed 2024-08-08 | $117.95M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $7.00K 10-Q · filed 2024-05-15 | $117.95M derived: sum of 2 quarters · filed 2024-05-15 | $117.95M derived: sum of 3 quarters · filed 2024-05-15 | |
| 2022-12-31 | $117.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $117.94M derived: sum of 2 quarters · filed 2024-03-01 | $117.97M 10-K · filed 2024-03-01 | |
| 2022-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $26.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $25.00K 10-Q · filed 2023-08-09 | |||
| 2021-12-31 | -$275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$4.10M derived: sum of 2 quarters · filed 2023-03-01 | -$4.09M 10-K · filed 2023-03-01 | |
| 2021-09-30 | -$3.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$3.81M 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $12.00K 10-Q · filed 2022-08-08 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $23.00K derived: sum of 3 quarters · filed 2023-03-01 | $14.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $23.00K derived: sum of 2 quarters · filed 2021-11-08 | $14.00K 10-Q · filed 2021-11-08 | $14.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $14.00K 10-Q · filed 2021-08-05 | $14.00K derived: sum of 3 quarters · filed 2022-02-28 | $15.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$9.00K 10-Q · filed 2021-05-06 | -$9.00K derived: sum of 2 quarters · filed 2022-02-28 | -$8.00K derived: sum of 3 quarters · filed 2022-02-28 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.00K derived: sum of 2 quarters · filed 2022-02-28 | $22.00K 10-K · filed 2022-02-28 | |
| 2019-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $22.00K 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $21.00K 10-Q · filed 2020-08-10 | |||
| 2018-12-31 | -$2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$2.86M derived: sum of 2 quarters · filed 2021-02-26 | -$11.79M derived: sum of 3 quarters · filed 2021-02-26 | -$7.32M 10-K · filed 2021-02-26 |
| 2018-09-30 | -$572.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$9.50M derived: sum of 2 quarters · filed 2019-11-08 | -$5.03M 10-Q · filed 2019-11-08 | -$5.03M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$8.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$4.46M 10-Q · filed 2019-08-05 | -$4.45M derived: sum of 3 quarters · filed 2020-02-27 | $3.46M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $4.47M 10-Q · filed 2019-05-10 | $4.47M derived: sum of 2 quarters · filed 2020-02-27 | $12.39M derived: sum of 3 quarters · filed 2020-02-27 | $9.40M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $7.91M derived: sum of 2 quarters · filed 2020-02-27 | $4.93M derived: sum of 3 quarters · filed 2020-02-27 | $4.93M 10-K · filed 2020-02-27 |
| 2017-09-30 | $7.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $4.93M derived: sum of 2 quarters · filed 2018-11-08 | $4.93M 10-Q · filed 2018-11-08 | $4.93M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | -$2.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$2.98M 10-Q · filed 2018-08-02 | -$2.98M derived: sum of 3 quarters · filed 2019-02-28 | -$2.98M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $0.00 derived: sum of 3 quarters · filed 2019-02-28 | -$18.98M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | -$18.98M derived: sum of 3 quarters · filed 2019-02-28 | -$9.49M 10-K · filed 2019-02-28 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$18.98M derived: sum of 2 quarters · filed 2017-11-08 | -$9.49M 10-Q · filed 2017-11-08 | -$6.49M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | -$18.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$9.49M 10-Q · filed 2017-08-09 | -$6.49M derived: sum of 3 quarters · filed 2018-02-28 | -$3.37M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $9.49M 10-Q · filed 2017-05-10 | $12.49M derived: sum of 2 quarters · filed 2018-02-28 | $15.61M derived: sum of 3 quarters · filed 2018-02-28 | |
| 2015-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $6.12M derived: sum of 2 quarters · filed 2018-02-28 | $13.39M 10-K · filed 2018-02-28 | |
| 2015-09-30 | $3.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $10.39M 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | $7.27M 10-Q · filed 2016-08-09 | |||
| 2014-12-31 | $4.55M 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |